JPS5921617A - 抗アレルギ−剤 - Google Patents

抗アレルギ−剤

Info

Publication number
JPS5921617A
JPS5921617A JP58120910A JP12091083A JPS5921617A JP S5921617 A JPS5921617 A JP S5921617A JP 58120910 A JP58120910 A JP 58120910A JP 12091083 A JP12091083 A JP 12091083A JP S5921617 A JPS5921617 A JP S5921617A
Authority
JP
Japan
Prior art keywords
fructose
sodium salt
agent according
item
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58120910A
Other languages
English (en)
Japanese (ja)
Inventor
ジユセツペ・ラツアリ−ノ
ルチアノ・カツタ−ニ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica Foscama Industria Chimico Farmaceutica SpA
Original Assignee
Biomedica Foscama Industria Chimico Farmaceutica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Foscama Industria Chimico Farmaceutica SpA filed Critical Biomedica Foscama Industria Chimico Farmaceutica SpA
Publication of JPS5921617A publication Critical patent/JPS5921617A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP58120910A 1982-07-02 1983-07-01 抗アレルギ−剤 Pending JPS5921617A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22202/82A IT1156103B (it) 1982-07-02 1982-07-02 Preparato di fruttosio-1,6-difosfato ad azione antiallergica
IT22202A/82 1982-07-02

Publications (1)

Publication Number Publication Date
JPS5921617A true JPS5921617A (ja) 1984-02-03

Family

ID=11192981

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58120910A Pending JPS5921617A (ja) 1982-07-02 1983-07-01 抗アレルギ−剤

Country Status (4)

Country Link
JP (1) JPS5921617A (fr)
DE (1) DE3323848A1 (fr)
FR (1) FR2529459A1 (fr)
IT (1) IT1156103B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100431503B1 (ko) * 2001-07-07 2004-05-14 주식회사 태평양 자외선에 의한 피부세포 손상을 억제하는 프럭토스1,6-디포스페이트 및 그의 염을 함유한 화장료 조성물
KR100836033B1 (ko) * 2002-05-27 2008-06-09 (주)아모레퍼시픽 프럭토스 1,6-디포스페이트 또는 그 유도체를 함유한미백용 피부외용제 조성물

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8904354D0 (sv) * 1989-12-21 1989-12-21 Matti Siren A pharmaceutical composition
US5654280A (en) * 1989-12-21 1997-08-05 Perstorp Ab Pharmaceutical composition
US5858985A (en) * 1997-10-03 1999-01-12 Markov; Angel K. Treatment of asthma with fructose-1,6-diphosphate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6065M (fr) * 1966-11-25 1968-05-27
US3931402A (en) * 1970-12-02 1976-01-06 Societa Prodotti Antibiotici S.P.A. Preparations containing hexoses
DE2508474A1 (de) * 1975-02-27 1976-09-02 Boehringer Mannheim Gmbh Infusions- und spuelfluessigkeiten zur behandlung von hirnoedemen
IT1143956B (it) * 1980-03-12 1986-10-29 Foscama Biomed Chim Farma Preparato di fruttosio-1,6-difosfato ad azione protettiva della membrana degli eritrociti in pazienti sottoposti a circolazione extracorporea
IT1170618B (it) * 1981-01-13 1987-06-03 Foscama Biomed Chim Farma Preparato farmacologico di frutto sio-1,6-difosfato ad azione terapeutica nei pazienti ustionati

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100431503B1 (ko) * 2001-07-07 2004-05-14 주식회사 태평양 자외선에 의한 피부세포 손상을 억제하는 프럭토스1,6-디포스페이트 및 그의 염을 함유한 화장료 조성물
KR100836033B1 (ko) * 2002-05-27 2008-06-09 (주)아모레퍼시픽 프럭토스 1,6-디포스페이트 또는 그 유도체를 함유한미백용 피부외용제 조성물

Also Published As

Publication number Publication date
FR2529459A1 (fr) 1984-01-06
DE3323848A1 (de) 1984-12-20
IT1156103B (it) 1987-01-28
IT8222202A0 (it) 1982-07-02

Similar Documents

Publication Publication Date Title
Stevenson et al. Oral aspirin challenges in asthmatic patients: a study of plasma histamine
Nelson et al. Influence of the absorption rate of tolbutamide on the rate of decline of blood sugar levels in normal humans
Cox et al. Nature and modes of action of disodium cromoglycate (Lomudal®)
Sershen et al. Noncholinergic, saturable binding of (±)-[3H] nicotine to mouse brain
CH639854A5 (de) Gefriergetrocknetes natives gammaglobulin-praeparat zur intravenoesen verabreichung und verfahren zu seiner herstellug.
JPS60500174A (ja) 消化性潰瘍治療用医薬製剤
Clarke Adverse effects of intravenously administered drugs used in anaesthetic practice
JPS5921617A (ja) 抗アレルギ−剤
Walser et al. Reciprocal creatinine slopes often give erroneous estimates of progression of chronic renal failure.
DE2301501B2 (de) Verfahren zur gewinnung eines stabilen, von hypotensiven stoffen freien plasmaproteins
Guggenheim et al. Clinical Studies of an Interferon Inducer, Polyriboinosinic-Polyribocytidylic Acid [Poly (I)• Poly (C)], in Children
Nabe et al. The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis
DE2734150A1 (de) Verfahren zur gewinnung von human- lysozym
DE2658170A1 (de) Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen
Linder et al. Random distribution of exogenous lithium in nasal secretion and its application in substance determination
Flippin et al. Sulfapyridine and sulfathiazole therapy in pneumococcic pneumonia
JPH0240327A (ja) 腎疾患治療剤
Neumann et al. Release of chemoattractants and neutrophil activation in acute myocardial infarction immediately after successful recanalization of the infarct-related vessel by angioplasty
Bryant et al. Histamine content of sputum from patients with asthma and chronic bronchitis
Norris et al. Modulation of neurogenic inflammation in rat trachea
Gibbons et al. Cell-mediated immunity in patients with cystic fibrosis.
Cesario et al. Affinity of human fibroblast interferon for blue dextran
Chan et al. Effects of decoctions prepared from Aconitum carmichaeli, Aconitum kusnezoffii and Tripterygium wilfordii on serum lactate dehydrogenase activity and histology of liver, kidney, heart and gonad in mice
EL Histamine and the antihistaminic drugs.
JP3647895B2 (ja) アレルギー性疾患予防及び治療剤